Y8Y-19234-05298
2 vaccinations
7 coded responses
22 check-ins
7 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 41-45
- ZIP prefix
- 301 / GA
- Registered
- 2021-07-21
- Relationship
- Self
- Race
- Black or African American
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-07-21
Registered in v-safe
-
2021-07-21
Dose 1 — Pfizer-BioNTech
-
2021-07-21
Survey response — day 0, dose 1MedDRA: Headache — Feeling: GoodFree text: Very Mild headacheMedDRA releases: 2024-11 · check-in free text available
- 2021-07-22
-
2021-07-23
Survey response — days 1–6 daily, dose 1MedDRA: Hyperhidrosis — Feeling: GoodFree text: SweatingMedDRA releases: 2021-09,2024-11 · check-in free text available
- 2021-07-24
- 2021-07-25
- 2021-07-26
-
2021-07-27
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Muscle or body aches, Abdominal painAdult check-in
-
2021-07-28
Survey response — day 7, dose 1MedDRA: Myalgia — Feeling: Good · Muscle or body achesFree text: Very slight muscle pain still in my chest cavityMedDRA releases: 2021-09,2024-11 · check-in free text available
- 2021-08-04
-
2021-08-16
Dose 2 — Pfizer-BioNTech
-
2021-08-18
Survey response — days 1–6 daily, dose 2MedDRA: Hyperhidrosis — Feeling: Good · Muscle or body achesFree text: Sweating terriblyMedDRA releases: 2021-09,2024-11 · check-in free text available
- 2021-08-19
- 2021-08-20
-
2021-08-22
Survey response — days 1–6 daily, dose 2MedDRA: Hyperhidrosis — Feeling: GoodFree text: Continuous SweatingMedDRA releases: 2021-09,2024-11 · check-in free text available
-
2021-08-23
Survey response — day 7, dose 2MedDRA: Hyperhidrosis — Feeling: Good · NauseaFree text: SweatingMedDRA releases: 2021-09,2024-11 · check-in free text available
- 2021-09-01
- 2021-09-08
- 2021-09-15
- 2021-09-22
- 2021-09-27
- 2021-11-15
-
2022-02-14
Survey response — 6 months, dose 2MedDRA: Asthenia, Cough, Pain — Feeling: Good · Be unable to work or attend schoolFree text: Body aches, cough, weaknessMedDRA releases: 2024-11 · check-in free text available
- 2022-08-16
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-07-21 | Pfizer-BioNTech | No |
| 2 | 2021-08-16 | Pfizer-BioNTech | No |
Free text
Release 9 — day 0, dose 1
Systemic reaction (other): Very Mild headache
Release 9 — days 1–6 daily, dose 1
Systemic reaction (other): Sweating
Release 9 — day 7, dose 1
Systemic reaction (other): Very slight muscle pain still in my chest cavity
Release 9 — days 1–6 daily, dose 2
Systemic reaction (other): Sweating terribly
Systemic reaction (other): Continuous Sweating
Release 9 — day 7, dose 2
Systemic reaction (other): Sweating
Release 11 — 6 months, dose 2
Symptoms: Body aches, cough, weakness
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Asthenia | · | · | ✓ |
| SD | Cough | · | · | ✓ |
| SD | Pain | · | · | ✓ |
| SRO | Headache | · | · | ✓ |
| SRO | Hyperhidrosis | ✓ | · | ✓ |
| SRO | Myalgia | ✓ | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release